Companies: 10,795·Total market cap: $144.5T
Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc.

ORMPNASDAQHealthcare● Active
$3.71
+$0.07(+1.92%)
Market Cap$151835761
P/E Ratio—
52W High$5.01
52W Low$1.98
Overview

Oramed Pharmaceuticals Inc. (ORMP) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001176309 · ORMP · NASDAQ · as of Jun 9, 2026

Filing snapshot

919
Total Filings
10-Q
Latest Form
2026-05-19
Most Recent
2007
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001176309 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-26
Fiscal Year End
Mar 26, 2026
Accession No.
0001213900-26-034835
Primary Document
ea0282618-10k_oramed.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001176309 · Accession 0001213900-26-034835

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2026-05-19
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2026-03-31Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
QUARTERLY REPORT
2026-05-19
View
NT 10-QNT 10-Q
NOTIFICATION OF LATE FILING
2026-05-15
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-05-14
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-05-14
View
8-KCurrent Report
CURRENT REPORT
2026-03-31
View
10-KAnnual Report
ANNUAL REPORT
2026-03-26
View
8-KCurrent Report
8-K
2026-02-20
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-02-19
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-09
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-01-29
View
8-KCurrent Report
CURRENT REPORT
2026-01-14
View
8-KCurrent Report
CURRENT REPORT
2026-01-07
View
8-KCurrent Report
CURRENT REPORT
2025-12-31
View
Showing 1–15 of 668 filingsForm 4 / 144 hidden· 919 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001176309  |  Exchange: NASDAQ · Healthcare

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) has submitted 919 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2007. As a Healthcare sector company with CIK 0001176309, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Oramed Pharmaceuticals Inc.'s most comprehensive regulatory disclosure. The most recent Oramed Pharmaceuticals Inc. 10-K was filed on 2026-03-26 for fiscal year ending 2026. Historical ORMP 10-K annual reports are available from 2002 through 2026.

Investors researching Oramed Pharmaceuticals Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
OVID SEC Filings →MGNX SEC Filings →STTK SEC Filings →CNTX SEC Filings →CNTB SEC Filings →IFRX SEC Filings →COYA SEC Filings →KLRS SEC Filings →
→ ORMP Financials→ ORMP Earnings→ ORMP Insider Trades

Frequently Asked Questions

ORMP SEC Filings · 8 questions

Oramed Pharmaceuticals Inc. (ORMP) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 919 filings and access original documents at no cost. Oramed Pharmaceuticals Inc.'s CIK is 0001176309.

ORMP SEC filingsOramed Pharmaceuticals Inc. SEC documentsfind ORMP 10-K